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Introduction {#sec1}
============

The AGM region plays an important role in development of HSCs that give rise to the adult hematopoietic system ([@bib24], [@bib30], [@bib34], [@bib31], [@bib9]). The pool of immature precursors (pre-HSCs), which cannot yet repopulate adult irradiated recipients, gradually expands and matures in the AGM region ([@bib44]). This concealed dramatic expansion of pre-HSCs culminates in the emergence of a few definitive (d)HSCs in the E11 AGM region followed by a sudden increase in their number in the E12 fetal liver, detectable by direct transplantation into adult irradiated recipients ([@bib24], [@bib12], [@bib44]).

Cell proliferation is one of critical factors involved in many developmental processes ([@bib8], [@bib25], [@bib21]), and the proliferative status of adult HSCs is an important feature of their biology. In the fetal liver, HSCs expand, probably through symmetric division until week 3--4 postnatally, then become quiescent ([@bib5]). Proliferative quiescence in the adult maintains "stemness" of HSCs and prevents their exhaustion ([@bib39], [@bib56], [@bib47], [@bib52], [@bib41], [@bib35]). Physiological demands drive HSCs to enter proliferation, while a balance is maintained to ensure HSC self-renewal and differentiation. The bone marrow niche maintains HSC quiescence through essential signaling ([@bib20], [@bib32], [@bib33]). By contrast, downstream committed progenitors, which are involved in the immediate production of mature blood cells, are significantly more proliferative ([@bib39]).

Given the importance of proliferation in cell commitment and differentiation, here we have studied proliferative changes during HSC maturation steps, which to date have not been studied in detail. We showed previously that in culture developing HSCs of the AGM region proliferate slower than committed progenitors ([@bib54]). More recent in vivo analysis of the dramatic pre-HSC expansion in the AGM region suggests that proliferation or/and cell recruitment may play a role ([@bib44]).

In vitro modeling has proved to be a powerful and informative approach for the identification of pre-HSC states and dissection of HSC developmental mechanisms ([@bib54]). HSCs develop through a multi-step process: pro-HSC → pre-HSC I → pre-HSC II → dHSC, which involves sequential upregulation of hematopoietic markers CD41 (Itga2b), RUNX1 (AML1), CD43 (Spn), and CD45 (Ptprc) in VE-CADHERIN^+^ (VC) precursors ([@bib42], [@bib43], [@bib54], [@bib30], [@bib27], [@bib51], [@bib58]). Pro-HSCs (VC^+^CD41^lo^CD43^−^CD45^−^) emerge at embryonic day 9.5 (E9.5), pre-HSCs type I (VC^+^CD41^lo^CD43^+^CD45^−^) at E10.5, and pre-HSCs type II (VC^+^CD41^lo^CD43^+^CD45^+^) at E11.5 stages. Low dHSC numbers emerge at E11.5 and, although phenotypically similar to pre-HSCs type II, they can be detected by direct transplantations into irradiated recipients. Pro-/pre-HSCs have been identified in hematopoietic clusters budding from the endothelium of major embryonic arteries ([@bib42], [@bib43], [@bib54], [@bib60], [@bib23], [@bib3], [@bib17], [@bib9]).

Functional assessment of cell proliferation in live cells often involves Hoechst staining, which can be toxic and can alter the experimental outcome ([@bib38]). Instead, we used the fluorescent ubiquitination-based reporter (Fucci) system, which enables noninvasive in vivo visualization of the cell-cycle status and their isolation for functional analysis ([@bib45], [@bib57], [@bib62]).

We describe here that pro-HSCs (at E9.5) initially slowly cycle, then enter active proliferation during E10.5--E11.5, which correlates with the expansion of the pro-/pre-HSC pool ([@bib44]). However, this phase is followed by gradual slowing down of proliferation, the first signs of which can be already observed in AGM dHSCs, in keeping with gradual acquisition of adult status by dHSCs. We also describe the orderly architectural evolvement of intra-aortic clusters in which stepwise HSC maturation and proliferation are linked. It is suggested that the proliferative pattern within the cluster is defined by c-KIT/SCF signaling.

Results {#sec2}
=======

Changes in Proliferative Status of Developing HSCs {#sec2.1}
--------------------------------------------------

To analyze the proliferative status of developing HSCs, we used the Fucci dual reporter mouse lines (see [Experimental Procedures](#sec4){ref-type="sec"}) appropriate for analysis of the hematopoietic system ([@bib57], [@bib62]). Two anti-phase oscillating proteins that mark cell-cycle transitions Cdt1 (genetically labeled by mKO2; red fluorescence) and Geminin (genetically labeled by mAG; green fluorescence), which are controlled by the cell-cycle machinery through proteasomal degradation, have been used here as reporters. Cdt1-mKO2 is expressed during G~0~ and G~1~ phases and the cells fluoresce red, while Geminin-mAG (Gem-mAG) marks green the cells that are in S/G~2~/M phases ([Figures 1](#fig1){ref-type="fig"}A and [S1](#mmc1){ref-type="supplementary-material"}A). During the G~1~/S transition cells become yellow and no reporter is expressed in early G~1~ phase (shown as gray) ([Figures 1](#fig1){ref-type="fig"}A and [S1](#mmc1){ref-type="supplementary-material"}A). Therefore, slowly cycling populations are represented mainly by red (Cdt1-mKO2^+^) cells and actively cycling populations are mainly green (Gem-mAG^+^) cells.Figure 1Changes in Proliferative Status of Developing HSCs(A) Representation of cell-cycle analysis by Fucci reporters.(B) Experimental design of transplantation assays of pro-/pre-HSCs and dHSCs.(C) Flow-cytometry analysis of HSC precursors and committed progenitors in Fucci embryos at different developmental stages (three independent experiments) shown by bar graphs (error bars show SEM) and representative dot plots. All the populations analyzed are gated on Live Ter119^−^ cells. The pro-HSC population is identified as VC^+^CD45^−^CD41^lo^CD43^−^, while the progenitors are VC^+^CD45^−^CD41^lo^CD43^+^. The pre-HSC type I population is identified as VC^+^CD45^−^CD41^lo^CD43^+^, while the E10.5 progenitors are VC^+^CD45^+^. The pre-HSC type II population is identified as VC^+^CD45^+^CD41^lo^CD43^+^ and the E11.5 progenitors as VC^−^CD45^+^. ^∗^p \< 0.05, ^∗∗^p \< 0.01, ^∗∗∗^p \< 0.005.(D) Transplantation assays of pro-/pre-HSCs and dHSCs after sorting on the basis of the Geminin-mAG reporter (at least three independent experiments). ^∗^p \< 0.05, ^∗∗^p \< 0.01, ^∗∗∗∗^p \< 0.0001.(E) Transplantation assays of fetal liver (LSK CD48^−^) HSCs and bone marrow (LSK CD150^+^CD48^−^) HSCs after sorting on the basis of the Fucci reporters (2--3 independent experiments). The dashed line shows the 5% chimerism threshold and the error bars show SEM. ^∗^p = 0.02, ^∗∗^p = 0.005, ^∗∗∗^p = 0.0006, ^∗∗∗∗^p \< 0.0001.See also [Figure S1](#mmc1){ref-type="supplementary-material"} and [Table S1](#mmc1){ref-type="supplementary-material"}.

Flow-cytometry analysis of Fucci reporter embryos showed that in the caudal part of the E9.5 embryo endothelial cells were mainly within S/G~2~/M and early G~1~ phases, indicating that they were actively proliferative. Only 6.6% (±1.6%) of the endothelial population (VC^+^CD45^−^CD41^−^CD43^−^) were found in the G~0~/G~1~ phases of the cell cycle (versus 54.8% ± 11.9% in S/G~2~/M, p = 0.0002) ([Figure S1](#mmc1){ref-type="supplementary-material"}B). By contrast, a significant proportion of cells in the pro-HSC population (VC^+^CD45^−^CD41^lo^CD43^−^) were in G~0~/G~1~ phases (23.7% ± 7.6% versus G~0~/G~1~ endothelial population, p = 0.004), suggesting that a fraction of these cells emerging from the endothelium slow down their cycling ([Figure 1](#fig1){ref-type="fig"}C). Compared with the pro-HSC population, more committed hematopoietic progenitors (VC^−^CD45^−^CD41^lo^CD43^+^) ([@bib43]) were actively proliferating (progenitors, 8.6% ± 9.3% versus pro-HSC, 23.7% ± 7.6% in G~0~/G~1~; p = 0.02) ([Figure 1](#fig1){ref-type="fig"}C). To functionally define the cell-cycle status of pro-HSCs, we sorted Gem-mAG^+^ and Gem-mAG^−^ fractions of this population, co-aggregated them with OP9 cells for 7 days in culture, and transplanted them into irradiated recipients, as described previously ([@bib43]) ([Figure 1](#fig1){ref-type="fig"}B). Only the Gem-mAG^−^ fraction generated transplantable dHSCs, suggesting that pro-HSCs are slowly cycling ([Figure 1](#fig1){ref-type="fig"}D and [Table S1](#mmc1){ref-type="supplementary-material"}). Meanwhile, both Gem-mAG^+^ and Gem-mAG^−^ fractions of the pro-HSC population were able to generate colonies of myeloid cells in methylcellulose CFU-C assays ([Figure S1](#mmc1){ref-type="supplementary-material"}C).

While the E9.5 endothelium is mainly proliferating, this population slows down its cycle during the following days of development since the proportion of G~0~/G~1~ endothelial cells increases to 47% (±6.1) by E11.5 (versus E9.5: 6.6% ± 1.6%, p \< 0.0001) ([Figure S1](#mmc1){ref-type="supplementary-material"}B). In contrast to pro-HSCs observed in E9.5--10.5 embryos, the proportion of E10.5 pre-HSC type I (VC^+^CD45^−^CD41^lo^CD43^+^) in the G~0~/G~1~ phases decreased to 8.5% (±6.7%) (versus E10.5 pro-HSC: 19.2% ± 4%, p = 0.03), suggesting that by this stage the HSC lineage becomes more proliferative ([Figure 1](#fig1){ref-type="fig"}C). Indeed, functional validation using ex vivo maturation and transplantation showed that in contrast to E9.5 pro-HSCs, pre-HSC type I resided in both the Gem-mAG^+^ and Gem-mAG^−^ fraction, which is in line with the dramatic expansion of the pre-HSC pool at E10.5 ([Figure 1](#fig1){ref-type="fig"}D and [Table S1](#mmc1){ref-type="supplementary-material"}) ([@bib44]). We observed higher repopulation levels from the Gem-mAG^+^ fraction but no bias in multi-lineage differentiation compared with the Gem-mAG^−^ fraction (data not shown). Similar to the E9.5 pro-HSC population, both Gem-mAG^+^ and Gem-mAG^−^ fractions of E10.5 pre-HSC type I were equally capable of generating myeloid colonies in the methylcellulose ([Figure S1](#mmc1){ref-type="supplementary-material"}C).

By E11.5, immunophenotypic analysis showed a dramatic increase of G~0~/G~1~ cells in the pre-HSC type I population compared with E10.5, from 8.5% ± 6.7% to 51.3% ± 10.3% (p = 0.02), respectively ([Figure 1](#fig1){ref-type="fig"}C). By contrast, the more advanced pre-HSC type II population (VC^+^CD45^+^CD41^lo^CD43^+^Sca1^+^) was found mainly in early G~1~ and S/G~2/~M phases associated with active cell cycling (19.3% ± 12.8% and 50.7% ± 3.7%, respectively versus G~0~/G~1~: 19.7% ± 7.9%, p = 0.02) ([Figure 1](#fig1){ref-type="fig"}C). Previous analysis showed that pre-HSCs emerge predominantly in the ventral domain of the dorsal aorta (AoV) with some contribution from the dorsal domain (AoD) ([@bib50], [@bib53]). Interestingly, immunophenotypic analysis at E11.5 revealed a larger proportion of the pre-HSC type I population in S/G~2~/M phases from the AoD compared with AoV (30% ± 7.1% versus 16.1% ± 8.7%, respectively; p = 0.02), which is reminiscent of committed progenitor cells ([Figure S1](#mmc1){ref-type="supplementary-material"}B). By contrast, no proliferative difference was observed between AoV- and AoD-derived endothelial or pre-HSC type II populations (data not shown).

A striking change in cell-cycle status was observed in pre-HSC type I by E11.5. Functional transplantations demonstrated that in contrast to E10.5, these cells resided almost exclusively in G~0~/G~1~, with only a few low repopulating cells residing in S/G~2~/M phases ([Figures 1](#fig1){ref-type="fig"}D and [S1](#mmc1){ref-type="supplementary-material"}D; [Table S1](#mmc1){ref-type="supplementary-material"}). By contrast, pre-HSCs type II were found in both Gem-mAG^+^ and Gem-mAG^−^ fractions ([Figure 1](#fig1){ref-type="fig"}D). Notably, direct transplantations (without prior culturing) showed that mature E11.5 dHSCs were in G~0~/G~1~ phases, indicating that acquisition of the adult status is accompanied by reducing cycling ([Figure 1](#fig1){ref-type="fig"}D and [Table S1](#mmc1){ref-type="supplementary-material"}). Although both E11.5 pre-HSCs and dHSCs were predominantly Gem-mAG^−^, CFU-C were equally well represented by both Gem-mAG^+^ and Gem-mAG^−^ fractions ([Figure S1](#mmc1){ref-type="supplementary-material"}C).

When we analyzed E14.5 fetal liver, we found that the majority of HSCs were also within G~0~/G~1~ or early G~1~ phases (G~0~/G~1~: 44.8% ± 6.7%) and became quiescent in the adult bone marrow (G~0~/G~1~: 93.1% ± 1.4%) ([Figure S1](#mmc1){ref-type="supplementary-material"}B), in contrast to restricted progenitors (G~0~/G~1~ 10.2% ± 0.8% in FL, p = 0.0005; G~0~/G~1~ 69.2.8% ± 2.6% in BM, p = 0.0002) ([Figure S1](#mmc1){ref-type="supplementary-material"}B). These findings in combination with transplantation assays ([Figure 1](#fig1){ref-type="fig"}E and [Table S1](#mmc1){ref-type="supplementary-material"}) are in line with previous reports ([@bib5], [@bib6], [@bib39]). Based on limiting dilution transplantation analysis ([Figure 1](#fig1){ref-type="fig"}E) (ELDA; [@bib18]), the numbers of fetal liver HSCs in G~0~/G~1~ phase were 17/100 cells and in S/G~2~/M phases were 0.3/100 cells.

Proliferative Structure of Intra-aortic Hematopoietic Clusters {#sec2.2}
--------------------------------------------------------------

HSCs and more committed progenitors develop in hematopoietic clusters that are budding from the endothelium of major arteries during E10.5 ([@bib16], [@bib36], [@bib60], [@bib42], [@bib4]). Fucci mice allowed us to visualize the cell-cycle status within intra-aortic clusters. In the E9.5 embryo (caudal part), hematopoiesis occurs in two locations: pro-HSCs (CD41^+^CD43^−^) develop in the dorsal aorta and committed progenitors (CD41^+^CD43^+^) form a string of large cell clusters in the omphalomesenteric artery (OMA) ([@bib63], [@bib43]). Hematopoietic cells are marked in these locations by the transcription factor Runx1, including flat cells integrated in the endothelial lining of the dorsal aorta ([Figures 2](#fig2){ref-type="fig"}A and 2A′) ([@bib51], [@bib43]). We sought to identify candidate pro-HSCs using the Fucci reporters. We found a few VC^+^RUNX1^+^ cells, closely associated with the endothelium of the dorsal aorta, which are labeled by CD41 but not CD43 ([Figures 2](#fig2){ref-type="fig"}A, 2A′, [S2](#mmc1){ref-type="supplementary-material"}A, and S2A′) and which were also Cdt1-mKO2^+^ (Geminin-mAG^−^) ([Figures 2](#fig2){ref-type="fig"}B and 2B′), characteristic of pro-HSCs identified by functional analysis ([Figure 1](#fig1){ref-type="fig"}D). It is conceivable that true low-expressing CD41+ pro-HSCs were not detectable using this immunofluorescence analysis. Our previous study showed that committed progenitors localized in the OMA are labeled by CD43 ([@bib43]). Indicative of their active proliferation, the majority of OMA CD43^+^ cells were Geminin-mAG^+^ (Cdt1-mKO2^−^) both by flow cytometry ([Figure 1](#fig1){ref-type="fig"}C) and confocal analysis ([Figures 2](#fig2){ref-type="fig"}C, 2C′, [S2](#mmc1){ref-type="supplementary-material"}B, and S2B′).Figure 2Localization and Cell-Cycle Status of CD41^+^Runx1^+^ Cells in the E9.5 Embryo(A and A′) Wild-type E9.5 embryos stained against Runx1 and CD41. Low-magnification image (A) shows the Ao and OMA, while high magnification (A′) shows the localization of VC^+^CD41^+^Runx1^+^ single cell in the dorsal aorta (white arrowhead) (at least three embryos).(B) Geminin-mAG and (B′) Cdt1-mKO2 embryos stained against CD41 showing that pro-HSC phenotype cells (white arrowheads) in the dorsal aorta are in G~0~/G~1~ (at least three embryos).(C) Geminin-mAG and (C′) Cdt1-mKO2 embryos stained against CD43 showing that progenitors (VC^+^CD43^+^) are specifically localized in OMA and they are Geminin-mAG^+^Cdt1-mKO2^−^ (at least three embryos). Dashed line shows the endothelium of the OMA.Ao, dorsal aorta; OMA, omphalomesenteric artery; A, D, P, V, anterior, distal, posterior, ventral, respectively. Scale bars: (A) 40 μm; (A′, B, B′, C, C′) 10 μm. See also [Figure S2](#mmc1){ref-type="supplementary-material"}.

It is reasonable to assume that intra-aortic cell clusters are formed through budding from the endothelium of the dorsal aorta and may gradually build up through proliferation. Confocal analysis showed that the base of E10.5 clusters was VC^+^CD41^+^RUNX1^+^ (and also c-KIT^+^) but not CD43^+^, and therefore harbored the most immature pro-HSC population ([Figures 3](#fig3){ref-type="fig"}B, 3B′, and [S3](#mmc1){ref-type="supplementary-material"}). Notably, these cells closely associated with endothelium were in G~0~/G~1~ phases (Geminin-mAG^−^/Cdt1-mKO2^+^) ([Figures 3](#fig3){ref-type="fig"}A, 3B, and 3B′) as E9.5 pro-HSCs ([Figure 1](#fig1){ref-type="fig"}D). These G~0~/G~1~ cells at the base were observed in 67%--100% of clusters in four analyzed embryos ([Table 1](#tbl1){ref-type="table"}). Meanwhile, more apically located cells, presumably derived from the basal cells, were in S/G~2~/M phases (Geminin-mAG^+^/Cdt1-mKO2^−^). Among these actively proliferating more apical cells were the VC^+^CD43^+^CD45^−^ pre-HSC type I population and the committed VC^+^CD43^+^CD45^+^ progenitor population (note that pre-HSC type II are rare at this stage; [Figures 3](#fig3){ref-type="fig"}B, 3B′, [S2](#mmc1){ref-type="supplementary-material"}C, and S2C′) ([@bib42], [@bib43]). Similar polarized basal-apical organization was observed in the usually significantly larger hematopoietic clusters of extra-embryonic (vitelline and umbilical) arteries ([Figures S4](#mmc1){ref-type="supplementary-material"}A--S4B′).Figure 3Proliferative Structure of Intra-aortic Hematopoietic Clusters(A) E10.5 live section of Fucci embryo showing that cells at the base of the cluster are Geminin-mAG^-^Cdt1-mKO2^+^ (white arrowheads) (three embryos).(B and C) Geminin-mAG and (B′, C′) Cdt1-mKO2 embryos stained for CD43 (B, B′) at E10.5 and CD45 (C and C′) at E11.5 to identify pro-/pre-HSCs (at least three embryos).(D) Wild-type embryos stained against Ki67 (three embryos). White arrowheads show the cells at the base of the cluster.Scale bars: (A) 25 μm; (B, B′, C, C′, D) 10 μm. See also [Table 1](#tbl1){ref-type="table"} and [Figures S2--S4](#mmc1){ref-type="supplementary-material"}.Table 1Proliferative Structure of Intra-aortic Hematopoietic ClustersSampleNo. of Clusters with VC^+^CD45^−^Cdt1^+^ BaseTotal No. of Clusters% Clusters with Cdt1^+^ BaseE10.5Embryo 11212100Embryo 2141974Embryo 3212487Embryo 46967E11.5Embryo 14580Embryo 2121580Embryo 361540Embryo 4121489Embryo 53560[^1]

By the next day (E11.5), when HSC precursors have matured further, we analyzed phenotypic changes in intra-aortic clusters. The base of E11.5 intra-aortic clusters was again represented by cells mainly in G~0~/G~1~ phases (Geminin-mAG^−^/Cdt1-mKO2^+^), which by this time upregulated CD43 and acquired a pre-HSC type I phenotype (CD45^−^) ([Figures 3](#fig3){ref-type="fig"}C and 3C′), as observed in 40%--80% of clusters in individual embryos (n = 5) ([Table 1](#tbl1){ref-type="table"}). More apically located cells upregulated CD45^+^ and thus acquired pre-HSC type II phenotype and, as expected from functional transplantation studies, were both Geminin-mAG^+^ and Geminin-mAG^−^ ([Figures 3](#fig3){ref-type="fig"}C and 3C′).

Although Fucci analysis allowed us to visualize key phases of the cell cycle in the developing HSC lineage, this does not explain whether the cells are resting or cycling. To address this issue, we used antibody staining for Ki67 and found that all cells in the cluster, including those which are at its base (Cdt1^+^), were cycling ([Figure 3](#fig3){ref-type="fig"}D). Thus, Fucci analysis here reveals differences not between quiescent and cycling, but between slowly and rapidly cycling cells within the developing HSC lineage in the AGM region.

c-KIT Expression Correlates with Cell-Cycle Status in HSC Precursors {#sec2.3}
--------------------------------------------------------------------

The c-KIT/SCF signaling pathway is critically important for HSC development in the AGM region and in adult HSC niches ([@bib43], [@bib10]). Asymmetric, ventrally polarized expression of SCF in the AGM region correlates with predominant formation of intra-aortic clusters in the floor of the dorsal aorta ([@bib50]). Our analysis of E10.5 clusters showed that c-KIT^low^ cells in both intra-aortic and umbilical arteries were in G~0~/G~1~ phases, suggesting that they are slowly cycling ([Figures 4](#fig4){ref-type="fig"}A, 4A′, [S4](#mmc1){ref-type="supplementary-material"}C, and S4C′, white arrows). Although we observed c-KIT^low^ slowly proliferating cells in various positions, these were mostly localized to the base of the cluster, closely associated with endothelium ([Figures 4](#fig4){ref-type="fig"}A and 4A′). By contrast, high c-KIT levels correlated with actively proliferating Geminin-mAG^+^ cells localized mainly apically in the cluster ([Figures 4](#fig4){ref-type="fig"}A, 4A′, [S4](#mmc1){ref-type="supplementary-material"}C, and S4C′, white arrowheads). Accordingly, slowly cycling pre-HSCs type I (as shown functionally, [Figure 1](#fig1){ref-type="fig"}D, E11.5) were enriched for c-KIT^low^ cells (G~0~/G~1~: 53.2% ± 7.4% are c-KIT^lo^ versus 5.3% ± 1.7% are c-KIT^hi^, p = 0.0006) compared with more actively cycling pre-HSC type II (G~0~/G~1~: 48.1% ± 3.3% are c-KIT^lo^ versus 51.3% ± 3.2% are c-KIT^hi^, p = not significant; S/G~2~/M: 19.9% ± 2.6% are c-KIT^lo^ versus 65.9% ± 4.9% are c-KIT^hi^, p \< 0.0001) ([Figures 4](#fig4){ref-type="fig"}B and [Table S2](#mmc1){ref-type="supplementary-material"}), indicating that one of the roles of c-Kit/SCF signaling might be in expansion of the developing HSC pool ([@bib44]) through regulation of their proliferation ([@bib7], [@bib46], [@bib48]).Figure 4c-KIT Expression Correlates with Cell-Cycle Status in HSC Precursors(A) Localization and Intensity of c-KIT Expression in Intra-aortic Hematopoietic Clusters at E10.5 (A) Geminin-mAG and (A′) Cdt1-mKO2 embryos. White arrowheads show c-KIT^hi^ and Geminin-mAG^+^ (or in A′, Cdt1-mKO2^−^), while white arrows show c-KIT^lo^ and Cdt1-mKO2^+^ (or in A, Geminin-mAG^−^) (at least three embryos).(B) Representative dot plots of flow cytometry analysis of E11.5 AGM pre-HSCs and correlation of c-KIT expression level with cell-cycle status (three independent experiments).Scale bar, 10 μm. See also [Figures S3](#mmc1){ref-type="supplementary-material"} and [S4](#mmc1){ref-type="supplementary-material"}; [Table S2](#mmc1){ref-type="supplementary-material"}.

Discussion {#sec3}
==========

Cell proliferation plays an important role in various developmental processes. It underlies growth of tissues and organs and is involved in cell-fate decisions ([@bib15], [@bib40]). Proliferation is an important mechanism enabling self-renewal and differentiation of HSCs in the adult ([@bib5], [@bib41]). Here we used Fucci reporter mice to define the proliferative status of the developing HSCs. Our conclusions based on the ratio of Geminin-mAG^+^ and Cdt1-mKO2^+^ cells are consistent with previously described proliferation rates of fetal liver and bone marrow HSCs ([@bib5], [@bib6], [@bib37], [@bib7], [@bib52], [@bib15]).

During maturation, the developing HSC pool undergoes massive expansion within the AGM region before colonization of the fetal liver ([@bib44]). HSC maturation occurs through sequential upregulation of hematopoietic markers (CD41, CD43, and CD45) ([@bib54], [@bib43]). Fucci mice enabled visualization and isolation of cells in G~0~/G~1~ (red) and S/G~2~/M (green) phases, so that developing HSCs could be studied at both the phenotypic and functional levels ([Figure 5](#fig5){ref-type="fig"}A). We found that the Geminin-mAG^−^ but not Geminin-mAG^+^ fraction of the E9.5 pro-HSC population was able to mature into dHSCs, which could reconstitute adult irradiated recipients, indicating that pro-HSCs are not cycling or slowly cycling. By the next day (E10.5), upregulation of CD43 marks the emergence of pre-HSCs type I, which are actively proliferating since both Geminin-mAG^+^ and Geminin-mAG^−^ fractions can produce dHSCs. Thus, proliferation likely underlies the previously described dramatic expansion of the pre-HSC pool (from 5 cells at early E10 to 50 cells by late E10.5) ([@bib44]). At E11.5 pre-HSCs type II mature and continue to proliferate, with some bias toward the Geminin-mAG^−^ fraction, indicating a slowing down in this process, which becomes apparent in dHSCs. This slowing down of the cell cycle continues further in fetal liver HSCs and, finally, in mainly quiescent bone marrow HSCs ([Figure 5](#fig5){ref-type="fig"}A) ([@bib6], [@bib57]).Figure 5Model: Changes and Heterogeneity in Proliferative Status of the Developing HSC Lineage and Their Organization within the Intra-aortic Clusters(A) Analysis of Fucci reporter mice defined changes in the proliferative status of the HSC precursors during development. The dramatic expansion of the pre-HSC pool during E10.5 correlates with their active proliferation. There might be two scenarios to explain the appearance of slowly cycling pre-HSC type I in E11.5 AGM region; in scenario A a fraction of proliferative E10.5 pre-HSCs type I slows down their cycling and persists as type I until E11.5; in scenario B this is a retarded E9.5 pro-HSC fraction which matured into pre-HSC type I while maintaining slow cycling. Also, dHSCs are slowly cycling like their fetal liver counterparts, while the adult bone marrow HSCs are quiescent.(B) Slowly cycling cells are frequently found at the base of intra-aortic clusters, while more rapidly cycling cells are located at more apical positions. The proliferative organization of intra-aortic clusters is maintained during development of HSCs in the AGM region and is linked with their maturation. FL, fetal liver; BM, bone marrow; P, pro-HSC; I, pre-HSC type I; II, pre-HSC type II.

This study confirms our previous observations that certain states in HSC development can persist for longer than one developmental day ([@bib44]). However, while the proliferative status of E9.5 and E10.5 pro-HSCs is similar, pre-HSCs type I at E11.5 differ from E10.5 by their slow cycling. The origin of the slowly cycling E11.5 pre-HSC type I population is not clear. One possible scenario ([Figure 5](#fig5){ref-type="fig"}A, scenario A) is that a fraction of proliferative E10.5 pre-HSCs type I slows down their cycling and persists as type I until E11.5. Another scenario ([Figure 5](#fig5){ref-type="fig"}A, scenario B) is that a fraction of retarded E9.5 pro-HSCs matured into pre-HSC type I while maintaining their slow cycling. Whether these distinct pre-HSC fractions can contribute to the heterogeneity of the adult HSC pool ([@bib49], [@bib11], [@bib2], [@bib14]) needs further investigation. The G~0~/G~1~ status of E11.5 pre-HSC type I observed here contradicts a recent study reporting that these cells are predominantly in S/G~2~/M phases, which could be explained by their short-term monitoring of recipients that revealed committed progenitors rather than HSCs ([@bib61]).

The emergence of HSCs in the AGM region is manifested morphologically by the formation of intra-aortic hematopoietic clusters ([@bib42], [@bib43], [@bib54], [@bib60], [@bib23], [@bib3]). Although this process has not been investigated in detail experimentally, it could be assumed that endothelial-derived HSC precursors proliferate and mature to form the cluster. Our current functional analysis using Fucci mice allowed us to better define the identity of developing HSCs and dynamically map their location within intra-aortic clusters in a stage-specific manner. The day before clusters are formed, at E9.5, single slowly cycling cells of the VC^+^RUNX1^+^CD41^+^ phenotype were found attached to the aortic endothelium. However, since levels of CD41 expression detected under the microscope and by flow cytometry cannot be directly correlated, given the presence of few pro-HSCs per embryo ([@bib44]), this raises the possibility that true, CD41^low^ pro-HSCs escaped our analysis. By the next day when active formation of intra-aortic clusters occurs, slowly cycling (G~0~/G~1~) pro-HSCs remain associated with the endothelium at the base of the cluster, whereas actively cycling (S/G~2~/M) pre-HSCs type I emerge more apically ([Figure 5](#fig5){ref-type="fig"}B). By E11.5, the base of clusters still consists of slowly cycling cells, but these are now more mature pre-HSC type I. Again, more actively cycling pre-HSC type II develop in more apical positions. This organization was observed in at least 50% of intra-aortic clusters in E10.5 and E11.5 embryos. Similarly structured, although often significantly larger, hematopoietic cell clusters were also observed in extra-embryonic arteries. This suggests that clusters are initiated by slowly cycling precursors, which give rise to more mature actively proliferating precursors moving toward apical positions. This organization of clusters is maintained throughout their maturation, suggesting their growth through predominant expansion of more mature pre-HSCs. This maturation of clusters correlates with progressive quantitative expansion of the pre-HSC population identified functionally by transplantations ([@bib44]).

c-KIT/SCF signaling is essential for HSC biology ([@bib19], [@bib55], [@bib10], [@bib28]). We have shown that SCF is ventrally polarized in the AGM region and is a key regulator of stepwise pro-/pre-HSC transitions ([@bib50]). c-KIT is expressed in pro-/pre- and dHSCs, and is a principal marker for HSCs in the adult animal ([@bib43], [@bib22]). Since c-KIT/SCF signaling is implicated in the regulation of proliferation ([@bib46], [@bib13], [@bib1]), we studied the organization of c-KIT expressing cells in developing intra-aortic clusters and found that slowly cycling cells, including those at the base of the cluster, express low levels of c-KIT, whereas actively cycling cells express high levels of c-KIT. Although further experimentation is needed to understand this observation mechanistically, this suggests that the stratified proliferative architecture of the cluster is at least partly defined by c-KIT/SCF signaling. Our analysis provides a basis for investigation of cellular and molecular events in maturing intra-aortic clusters in connection with pro/pre-HSC expansion in the AGM region.

Cell proliferation plays an important role in various differentiation processes and needs to be tightly regulated. For example, lengthening G~1~ phase increases differentiation of neural stem cells into neurons ([@bib25], [@bib26]); cyclin D in human embryonic stem cells controls balance between neuroectoderm and endoderm specification ([@bib40]); and deletion of p27 cell-cycle inhibitor prevents specification of hematopoietic cells from the yolk sac endothelium ([@bib28]). The temporal kinetics of pre-HSC proliferation is well controlled: although mature fetal liver HSCs expand, their proliferative activity decreases compared with the AGM region and subsequently, in the adult bone marrow, switches into quiescence associated with low c-KIT expression, which is necessary to prevent exhaustion of the HSC pool ([@bib55], [@bib29], [@bib48]). Our data indicate that pre-HSC expansion within the AGM region is driven by proliferation. It needs to be elucidated in future whether stage-specific proliferative changes per se play a role in HSC maturation.

In summary, our analysis defines changes in proliferative status of the developing HSC lineage at pre-liver stages. We found that dramatic expansion of maturing HSCs correlates with their active proliferation, likely driven by c-KIT/SCF signaling. Proliferative analysis revealed previously concealed heterogeneity within the pre-HSC populations. We describe the proliferative organization of intra-aortic clusters that correlates with the functionally defined status of HSC precursors. This study lays a foundation for molecular analysis of mechanisms underlying HSC development within intra-aortic hematopoietic clusters.

Experimental Procedures {#sec4}
=======================

Mice {#sec4.1}
----

Mice were housed and bred in animal facilities at the University of Edinburgh in compliance with UK Home Office Regulations. Embryos for experiments were obtained from intercrossing heterozygous hCdt1(30/120)-mKO2 (\#610) and hGeminin(1/110)-mAG (\#474) mice ([@bib45], [@bib57], [@bib62]) or from C57BL/6 CD45.2/2 mice. The day of discovery of the vaginal plug was designated as day 0.5. The embryos were additionally staged based on somite pair (sp) numbers (E9.5 = 26--29 sp, E10.5 = 30--38 sp, E11.5 = 41--45 sp). C57BL/6 CD45.1/2 mice were used as transplant recipients and C57BL/6 CD45.1/1 as a source of carrier cells. All experiments with animals were approved under a Project License granted by the Home Office (UK) and the University of Edinburgh Ethical Review Committee, and conducted in accordance with local guidelines.

Flow Cytometry and Cell Sorting {#sec4.2}
-------------------------------

Single-cell suspensions from the AGM region or fetal liver were prepared by dispase/collagenase-mediated dissociation, while single-cell suspensions from bone marrow were obtained by flushing the tibias and femurs with a 26-gauge syringe needle (BD Microlance). Antibodies used for staining of cells were: anti-CD45-BV450 or BV650 (BD Horizon, clone 30F11), anti-VE-cadherin-A647 (BioLegend, Clone eBioBV13), biotinylated anti-VE-cadherin (clone 11.D4.1) followed by incubation with streptavidin-APC (BD Pharmingen), anti-CD43-PE or biotinylated anti-CD43 (eBioscience, clone eBioR2/60) followed by incubation with streptavidin-BV650 (BioLegend), anti-CD41-PE or BV421 (BioLegend, clone MWReg30), anti-Sca1-BV421 or PE-Cy7 (eBioscience, clone D7), anti-c-KIT/CD117-BV421 (BioLegend, clone 2B8), anti-CD150-APC (BioLegend, clone TC15-12F12.2), anti-CD48-PerCPefluor710 (BioLegend, clone HM48-1), anti-Ki67-AF647 (BD Pharmingen, clone B56), DAPI (Biotium), anti-Ter119-PerCp-Cy5.5 or biotinylated anti-Ter119 (eBioscience), biotinylated anti-B220/CD45R (eBioscience, clone RA3-6B2), biotinylated anti-CD3e (eBioscience, clone 145-2C11), and biotinylated anti-Gr1 (eBioscience, clone RB6-8C5). Lineage depletion of bone marrow and fetal liver samples was performed by streptavidin particles (BD IMag) according to the manufacturer\'s instructions. 7-Aminoactinomycin D viability staining solution, live-dead dye Zombie Aqua (BioLegend), or Infra-Red (Invitrogen) were used to exclude dead cells and gates were set using appropriate fluorescence minus one (FMO) controls. Flow-cytometry analysis was performed on a Fortessa LSR using FACSDiva software, while analysis was done using FlowJo 10. Sorting was performed on a FACSAriaII using FACSDiva software. Correlation analysis between c-KIT levels and cell-cycle phases was performed using GraphPad Prism. The different cell-cycle fractions were plotted against c-KIT in FlowJo and segmented in equal parts across the c-KIT axis. The cell numbers within each segment/gate were extracted from FlowJo and used for the correlation analysis. A correlation coefficient (r) of +1 indicates perfect positive correlation (i.e., when x increases then y increases), whereas −1 shows negative/inverse correlation (i.e., when x increases then y decreases). A correlation coefficient of 0 shows that the two variables do not vary at all. R^2^, or coefficient of determination, is the fraction of the variance in the two variables that is shared. The p values in this analysis show whether the correlation is due to random sampling. Nonlinear regression analysis was used to draw a graph with a smooth curve that fits the data.

OP9 Co-aggregates {#sec4.3}
-----------------

E9.5 caudal parts or E10.5--E11.5 AGM regions were isolated and for some experiments were subdissected into AoV, AoD, and UGRs. The notochord was included in the AoD. Sorted populations were co-aggregated with OP9 stromal cells as previously described ([@bib42], [@bib43]). In all experiments, 1 embryo equivalent (ee), defined as a unit of cells equivalent to the number present in one organ (e.g., 0.2ee corresponds to 20% of cells present in one AGM region), of sorted cells was co-aggregated with 100,000 OP9 cells. Cell aggregates were cultured at the liquid-gas interface on 0.8 μm of mixed cellulose MF-membranes (AAWP02500, Millipore) for 5--7 days (37°C, 5% CO~2~) in 5 mL of Iscove's modified Dulbecco's medium (IMDM, Invitrogen), 20% fetal calf serum (FCS; HyClone, ThermoScientific) supplemented with L-glutamine (4 mM), penicillin/streptomycin (50 units/mL) and 100 ng/mL SCF, 100 ng/ml IL-3, and 100 ng/mL Flt3l (all purchased from Peprotech). Suitable batches of FCS supporting effective maturation of pre-HSCs were selected after pre-testing in preliminary transplantation experiments ([@bib54]). Cells from E9.5--E10.5 AGM regions were cultured for 7 days, while cells from E11.5 AGM regions were cultured for 5 days.

HSC Transplantation and CFU-C Assay {#sec4.4}
-----------------------------------

AGM tissues from C57BL/6 CD45.2/2 embryos were pooled and cell suspensions obtained after dissociation with collagenase/dispase (Roche) for 40 min at 37°C. Dissociated cells were plated in methylcellulose culture that contains cytokines (MethoCult3434 medium; STEMCELL Technologies) according to the manufacturer\'s instructions. Donor cells were injected intravenously into C57BL/6 CD45.1/2 sublethally irradiated (1,150 rad) mice along with 50,000 C57BL/6 CD45.1/1 bone marrow carrier cells. The amount of transplanted cells is expressed in ee and the dose injected for each experiment was chosen based on the expected outcome of dHSC numbers, which can vary depending on the developmental stage.

Long-term hematopoietic repopulation by donor cells was assessed in peripheral blood between 14 and 16 weeks after transplantation. Peripheral blood was collected by bleeding the tail vein into 500 μL of 5 mM EDTA/PBS. Erythrocytes were depleted using PharM Lyse (BD Biosciences). Cells were stained with anti-CD16/32 (Fc-block), anti-CD45.1-V450 (cloneA20), and anti-CD45.2-APC (clone 104) monoclonal antibodies (eBioscience) and analyzed using a FACSCalibur. Data were analyzed in FlowJo software (TreeStar). Mice exhibiting \>5% of donor chimerism were considered to be repopulated with dHSCs. Different groups of repopulated mice were compared using one-way ANOVA or t test (^∗^p \< 0.05, ^∗∗^p \< 0.01, ^∗∗∗^p \< 0.005, ^∗∗∗∗^p \< 0.0001). Limiting dilution analysis of fetal liver was performed using ELDA software ([@bib18]).

Immunofluorescence {#sec4.5}
------------------

Whole-mount immunostaining was performed as previously described ([@bib59]) with slight modifications. Embryos dissected from the yolk sac and amnion were fixed with 2% paraformaldehyde or cold acetone and, following dehydration by increasing concentrations of methanol, the head, limbs, and one body wall were removed. After rehydration in 50% methanol, washing with PBS, and blocking in 50% FCS/0.5% Triton X-100, the samples were incubated overnight with antibodies. For staining with antibodies from the same species, incubations were performed sequentially. Primary antibodies used were unconjugated goat anti-mouse CD43 (Santa Cruz Biotechnology, clone M19), rat anti-mouse VE-cadherin (BD Pharmingen, clone 11D4.1), rat anti-mouse CD45 (BD Pharmingen, clone 30-F11), rabbit anti-mouse RUNX1 (Abcam, clone EPR3099), rat anti-mouse CD41 (BD Pharmingen, clone MWReg30), rat anti-mouse c-KIT (BioLegend, clone 2B8), rabbit anti-mouse Ki67 (Abcam, clone SP6), rabbit anti-mAG (MBL International), and rabbit anti-mKO2 (MBL International), and these were detected by the secondary antibodies anti-goat NL557 (R&D Systems), anti-rat Alexa Fluor 647 (Invitrogen), or anti-rat Alexa 488 (Invitrogen) and anti-rabbit Alexa Fluor 647 (Abcam). After washing, the embryos were dehydrated with methanol and cleared with BABB (one part benzyl alcohol, two parts benzyl benzoate) solution ([@bib60]). Secondary antibody only controls were used in all the experiments. Imaging of live sections was performed as previously described ([@bib3]) with slight modifications. E10.5 mouse embryos were dissected and cut into slices of 300-μm thickness using a tissue chopper. Slices were stained against c-KIT-APC (eBioscience, clone 2B8) for 10 min at 4°C, then placed in glass-bottom dishes (MatTek) and covered with low-melting-point agarose gel (4%). The gel was then covered with IMDM without phenol red. Images were acquired with an inverted confocal microscope (Leica SP8) and processed using Volocity software.
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[^1]: Intra-aortic clusters counted in E10.5 and E11.5 Cdt1-mKO2 embryos stained against CD45 and VC. The total number of clusters as well as the number/percentage of clusters with slowly cycling VC^+^CD45^−^Cdt1^+^ base counted is shown.
